SDZ-GLC-756

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSDZ-GLC-756
Drug Alias NameGLC-756SDZ-GLC-756
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonistsDopamine D1 receptor antagonists
TargetsDopamine D1 receptorDopamine D2 receptor
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A